Inozyme Pharma, Inc.
INZY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$102 | -$71 | -$67 | -$57 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $7 | $8 | $7 |
| Change in WC | $5 | -$3 | $2 | $0 |
| Other Non-Cash | -$3 | -$4 | -$1 | $0 |
| Operating Cash Flow | -$92 | -$71 | -$58 | -$48 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | -$0 |
| Inv. Purchases | -$155 | -$269 | -$152 | -$122 |
| Inv. Sales/Matur. | $222 | $216 | $147 | $165 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | $67 | -$54 | -$5 | $43 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $40 | $4 | $0 |
| Stock Issued | $11 | $86 | $56 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $13 | $1 |
| Financing Cash Flow | $11 | $126 | $73 | $1 |
| Forex Effect | $0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | -$14 | $2 | $10 | -$5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35 | $33 | $24 | $28 |
| End Cash | $21 | $35 | $33 | $24 |
| Free Cash Flow | -$92 | -$71 | -$58 | -$49 |